Advisor Group Holdings, Inc. Alx Oncology Holdings Inc Transaction History

Advisor Group Holdings, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$5.84 - $17.56 $29 - $87	5 Added 10.87%	51 $0
Q1 2024 May 10, 2024	SELL	$10.95 - $16.79 $394 - $604	-36 Reduced 43.9%	46 $0
Q4 2023 Feb 12, 2024	SELL	$4.81 - $15.38 $480 - $1,538	-100 Reduced 54.95%	82 $1,000
Q3 2023 Nov 13, 2023	BUY	$4.19 - $7.35 $762 - $1,337	182 New	182 $0
Q1 2022 May 04, 2022	BUY	$13.65 - $22.06 $1,774 - $2,867	130 New	130 $2,000

101

39.7M

134K

17.4K

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $68.9M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.